Stay updated with breaking news from Patent Coordination. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
While only slightly past the midway point of 2023, it has already been a busy year for developments in drug pricing. Notably, CMS released its final guidance in preparation for price...
During the February 9, 2023 Executive Business Meeting, Senate Judiciary Committee reported Interagency Patent Coordination and Improvement Act of 2023, Prescription Pricing for the People Act of 2023, Preserve Access to Affordable Generics and Biosimilars Act, and more.
It is hard to predict whether a given bill will gain traction, but when the Senate Judiciary Committee reports out five bipartisan bills targeting pharmaceutical patents and pricing, it...
Patent thickets, particularly those involving pharmaceutical patents, appear to have caught the ire of many U.S. senators. Within the past few weeks, two separate letters have urged...
Patent thickets, particularly those involving pharmaceutical patents, appear to have caught the ire of many U.S. senators.